BP001204-C424: Recombinant Human Anterior gradient protein 2 Homolog (AG-2) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001598-C553: Recombinant Human Anterior Gradient Protein 3 Homolog (AG-3) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP001598-PRO-242: Recombinant Human Anterior Gradient Protein 3 Homolog (AGR3) Protein
Source: E. Coli-derived.
Purity: > 90.0% by SDS-PAGE.BP002110-PRO-580: Recombinant Human Anterior Gradient Protein 2 Homolog (AGR2)
Source: E. Coli-derived.
Purity: > 95.0% as determined by: Analysis by RP-HPLC and SDS-PAGE.PA007276.r2a: In vivo Grade Recombinant Anti-mouse CD137 (TNFRSF9 or 4-1BB) Monoclonal Antibody, Rat IgG2a Kappa (Clone: 3H3)
Recombinant rat IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: 3H3) specifically binds to the mouse 4-1BB protein.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse 4-1BB protein.BP001649-CE68: Recombinant Human Breast Carcinoma-Amplified Sequence 2 (BCAS2) Protein
Source: E. coli-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001649-PRO-116: Recombinant Human Breast Carcinoma-Amplified Sequence 2 (BCAS2) Protein
Source: E. coli-derived.
Purity: > 85% by SDS-PAGE.APIM050347: CB-839 (TELAGLENASTAT)
CAS No.: 1439399-58-2.
Purity: 99.9% by HPLC.
QC: HPLC, 1H-NMR and Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.BP002889-PRO-343: Recombinant Human Estrogen Receptor Binding Site Associated Antigen 9 (EBAG9) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP001662-CE11: Recombinant Human Estrogen Receptor (ER) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).